Trial Evaluating an Investigational Agent for Management of Oral Melanoma
CURRENTLY ENROLLING
ANIMAL CLINICAL INVESTIGATION STUDY
DESCRIPTION
The Oncology Service is currently enrolling patients in a fully funded clinical trial for dogs with oral melanoma.
ELIGIBILITY CRITERIA
- Weighs at least 3 kg (6.6 lbs)
- Diagnosis of Stage III oral melanoma (not confined to lip)
- At least one measurable lesion with a longest diameter of ≥ 10 mm (≥ 15 mm short axis for lymph node lesions)
- Prior surgery acceptable (if performed at least 14 days prior to enrollment)if measurable disease remains which meets above criteria
- No lung metastasis
- No prior Oncept® melanoma vaccine
Other study inclusion and exclusion criteria apply. The veterinary investigator will decide if the dog is a good candidate for this study after examination.
REQUIREMENTS
Qualified dogs and their owners should expect to stay in the study for approximately 6 months and have 15 scheduled visits at The Oncology Service. Owners will also be required to document study associated observations as appropriate.
FULLY FUNDED STUDY BENEFITS
- Novel investigational product or placebo
- Study-related examinations and diagnostics
- Consultation and rechecks
Owners will receive a $100 Visa e-gift card if their dog enrolls in the study!
Referring veterinarians will receive a $100 Visa e-gift card if they refer a dog that enrolls in the study!
PARTICIPATING HOSPITALS
- The Oncology Service – Richmond, VA
- The Oncology Service – Springfield, VA
Interested?
Enroll or request more information below